17 May 2022 - A snapshot of the stocks on the move featuring, Havilah Resources, Oz Minerals, Calix, Pilbara Minerals, Brambles
17 May 2022 - A couple of stocks that have taken the eyes from the analysts', Coronado Global Resources (ASX:CRN), and Webjet (ASX:WEB).
Tech rout sends mixed signs on Wall St, James Hardie, Graincorp, Brambles, AUD on watch: ASX to rise
17 May 2022 - Wall St lacked conviction after learning that China's extended lockdowns could ease, sending oil prices higher while they digested a raft of economic print, including the April retail sales data. Investors find it difficult to shake of recession fears.
16 May 2022 - A snapshot of the stocks on the move, featuring Brambles (ASX:BXB), Chrysos Corp (ASX:C79), Boral (ASX:BLD) & Calix (ASX:CXL).
16 May 2022 - Oversold conditions attracted dip buyers and investors searching for beaten down stocks after 5 brutal days, following the Fed's decision the prior week. Deep dive of the YTD performance of the ASX and why amid a rising treasury yield environment. What to keep an eye out for the week.
13 May 2022 - A snapshot of the stocks on the move featuring Pro-Pac Packaging (ASX:PPG), Bigtincan (ASX:BTH) & Neometals (ASX:NMT).
13 May 2022 - Wall St closed mixed in another volatile session, following hot inflation figures in April for both consumers and producers. Deep dive on the Crypto collapse, featuring TerraUSD, Avalanche, Solana, Bitcoin. Janus Henderson (ASX:JHG) trades ex-dividend today.
12 May 2022 - Stealth Global Limited (ASX:SGI) CEO and Managing Director Mike Arnold discusses the company’s recently-released trading update.
12 May 2022 - US stocks fell across the board as investors assessed persistent inflation after the consumer price Index rose by an annual rate of 8.3 per cent. Some analysts see the data as a sign that the Fed is behind the curve in curbing inflation. CBA has delivered a $2.3b March quarter profit but warns of margin pressure. NAB has expressed interest in the banking arm of Suncorp.
11 May 2022 - A snapshot of stocks in the healthcare sector, including Antisense Therapeutics (ASX:ANP), Kazia Therapeutics (ASX:KZA), and Immutep (ASX:IMM).